Review article · 2025 · Open access
Fluid biomarkers for neurodegenerative diseases: a comprehensive update
Alzheimer s Research & Therapy, 18(1), 12 · Published 20 December 2025 · DOI 10.1186/s13195-025-01919-z
In brief
“Fluid biomarkers for neurodegenerative diseases: a comprehensive update” is a 2025 review article by Martina Valletta and 21 co-authors, published in Alzheimer s Research & Therapy. OpenAlex counts 26 citations as of 18 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Alzheimer s Research & Therapy.
- Citations
- 26
- Most cited in
- 2026 (26)
- Field-weighted impact
- 2.08
- References
- 176
- Authors
- 22
Abstract
Fluid biomarkers are revolutionizing the diagnosis and management of neurodegenerative diseases by enabling earlier diagnosis and disease monitoring. In particular, blood-based biomarkers have emerged as a minimally invasive and scalable alternative to cerebrospinal fluid analysis. Recent advances in blood-based tau biomarkers have shown high diagnostic accuracy for Alzheimer’s disease (AD). Other neurodegenerative diseases—such as synucleinopathies, frontotemporal lobar degeneration, limbic-predominant age-related TDP-43 encephalopathy (LATE), and amyotrophic lateral sclerosis—pose substantial challenges due to their heterogeneous clinical presentations and the current absence of robust biomarkers for hallmark pathologies. Nonetheless, promising candidate markers are emerging for improved disease characterization and staging. Technological innovations, including single-molecule arrays (Simoa), advanced mass spectrometry workflows and nucleic acid linked immune-sandwich assay (NULISA) have markedly enhanced the sensitivity and precision of biomarker quantification from low-concentration biological matrices. More recently, the development of fully automated platforms shows great promise for routine measurement of blood-based biomarkers in clinical settings. Despite this progress key challenges remain, including the need for improved assay reproducibility, standardization, and the optimization of clinical workflows. In this review, we provide a comprehensive update on recent progress in fluid biomarker research across AD and major neurodegenerative diseases, highlight technological advances in detection methods, and discuss current challenges and opportunities for clinical translation.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Valletta, M., Briel, N., Yuksekel, I., Barboure, M. C., Coward, A. R., De Houwer, J. F. H., Fawad, A., González-Mayoral, A., Iaccarino, G., Martínez‐Dubarbie, F., Moukaled, S., Andréasson, U., Gobom, J., Brinkmalm, A., Tijms, B. M., Zetterberg, H., Blennow, K., Suárez‐Calvet, M., Schöll, M., . . . Sogorb‐Esteve, A. (2025). Fluid biomarkers for neurodegenerative diseases: a comprehensive update. Alzheimer s Research & Therapy, 18(1), 12. https://doi.org/10.1186/s13195-025-01919-z
MLA 9
Valletta, Martina, et al. “Fluid biomarkers for neurodegenerative diseases: a comprehensive update.” Alzheimer s Research & Therapy, vol. 18, no. 1, 2025, p. 12. https://doi.org/10.1186/s13195-025-01919-z.
Chicago
Valletta, Martina, Nils Briel, Idil Yuksekel, Michelle C. Barboure, A. R. Coward, Julie F. H. De Houwer, Ayesha Fawad, et al. 2025. “Fluid biomarkers for neurodegenerative diseases: a comprehensive update.” Alzheimer s Research & Therapy 18 (1): 12. https://doi.org/10.1186/s13195-025-01919-z.
Harvard
Valletta, M. et al. (2025) ‘Fluid biomarkers for neurodegenerative diseases: a comprehensive update’, Alzheimer s Research & Therapy, 18(1), p. 12. doi:10.1186/s13195-025-01919-z.
IEEE
M. Valletta et al., “Fluid biomarkers for neurodegenerative diseases: a comprehensive update,” Alzheimer s Research & Therapy, vol. 18, no. 1, p. 12, 2025, doi: 10.1186/s13195-025-01919-z.
BibTeX
@article{valletta2025fluid,
title = {{Fluid biomarkers for neurodegenerative diseases: a comprehensive update}},
author = {Valletta, Martina and Briel, Nils and Yuksekel, Idil and Barboure, Michelle C. and Coward, A. R. and De Houwer, Julie F. H. and Fawad, Ayesha and González-Mayoral, Alberto and Iaccarino, Gianmarco and Martínez‐Dubarbie, Francisco and Moukaled, Shirine and Andréasson, Ulf and Gobom, Johan and Brinkmalm, Ann and Tijms, Betty Marije and Zetterberg, Henrik and Blennow, Kaj and Suárez‐Calvet, Marc and Schöll, Michael and Paterson, Ross W. and Montoliu‐Gaya, Laia and Sogorb‐Esteve, Aitana},
journal = {Alzheimer s Research \& Therapy},
year = {2025},
volume = {18},
number = {1},
pages = {12},
doi = {10.1186/s13195-025-01919-z},
url = {https://doi.org/10.1186/s13195-025-01919-z}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- fluid biomarkers
- blood-based biomarkers
- neurodegenerative diseases
- Alzheimer's disease
- tau biomarkers
- synucleinopathies
- frontotemporal lobar degeneration
- limbic-predominant age-related TDP-43 encephalopathy
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Valletta, M., Briel, N., Yuksekel, I., Barboure, M. C., Coward, A. R., De Houwer, J. F. H., Fawad, A., González-Mayoral, A., Iaccarino, G., Martínez‐Dubarbie, F., Moukaled, S., Andréasson, U., Gobom, J., Brinkmalm, A., Tijms, B. M., Zetterberg, H., Blennow, K., Suárez‐Calvet, M., Schöll, M., . . . Sogorb‐Esteve, A. (2025). Fluid biomarkers for neurodegenerative diseases: a comprehensive update. Alzheimer s Research & Therapy, 18(1), 12. https://doi.org/10.1186/s13195-025-01919-z
How many times has this paper been cited?
26 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Alzheimer s Research & Therapy: sign in and open the full text from this page.
Who wrote this paper?
Martina Valletta, Nils Briel, Idil Yuksekel, Michelle C. Barboure, A. R. Coward, Julie F. H. De Houwer, Ayesha Fawad, Alberto González-Mayoral, Gianmarco Iaccarino, Francisco Martínez‐Dubarbie, Shirine Moukaled, Ulf Andréasson and 10 more.
What is the DOI of this paper?
10.1186/s13195-025-01919-z, permanently at https://doi.org/10.1186/s13195-025-01919-z. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.